Home›Search›Expert Opinion on Pharmacotherapy

Expert Opinion on Pharmacotherapy

Taylor and Francis Ltd. · United Kingdom · Est. 1958

ISSN1744-7666

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q2+18

Total43

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

0.672

H-Index

116

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.675

Total Works

6,508

Total Citations

136,983

2yr Mean Citedness

3.21

Free JIF alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Inferred from recent articles

This journal focuses on pharmacotherapy across a wide range of conditions, including infectious diseases, hematologic malignancies, autoimmune disorders, neurological conditions, and metabolic diseases. It covers the development, efficacy, safety, and clinical application of both established and novel therapeutic agents, including small molecules, biologics, and long-acting injectables. The scope also extends to pharmacoeconomics and the implementation of pharmacotherapeutic strategies in various patient populations and healthcare settings.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 50% in field

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1958

Annual Volume~ 189 articles / year

StatusActive (last: 2026)

Total Publications6,508

Publisher OrgTaylor & Francis

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1744-7666

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q2

PharmacologyQ2

Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Pharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)Medicine (miscellaneous)

Research Topics (OpenAlex)

Diabetes Treatment and ManagementBlood Pressure and Hypertension StudiesAsthma and respiratory diseasesLipoproteins and Cardiovascular HealthSchizophrenia research and treatmentDiabetes Management and ResearchBipolar Disorder and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsHIV/AIDS drug development and treatmentTreatment of Major Depression